Min Lao, Xin Li, Yingjie Wang, Junlang Li, Zhengjie Tian, Jiale Zhang, Shaofeng Yin, Xiaoting Deng
{"title":"Electrospun porous nanofibers for sustained drug delivery: Degradation-controlled release through architectural design","authors":"Min Lao, Xin Li, Yingjie Wang, Junlang Li, Zhengjie Tian, Jiale Zhang, Shaofeng Yin, Xiaoting Deng","doi":"10.1016/j.colsurfb.2025.115126","DOIUrl":null,"url":null,"abstract":"<div><div>Diclofenac sodium (DS), a non-steroidal anti-inflammatory drug used for treating inflammatory pain, has a short elimination half-life, which can lead to fluctuations in blood drug concentration. Therefore, developing sustained-release formulations is necessary to meet clinical needs. Biodegradable polymers exhibit excellent sustained-release properties and good biocompatibility, making them suitable for processing into nanofiber-based drug delivery systems via electrospinning technology. Using electrospinning combined with a non-solvent-induced phase separation mechanism, porous nanofibers with different structures were successfully prepared, including non-porous uniaxial nanofibers, porous coaxial nanofibers, double-layered nanofibers with a porous mesh surface, and porous uniaxial nanofibers. The results demonstrated that drug release is influenced by fiber structure and morphology. Among these, the coaxial porous shell-core structure(NFs 2) achieved long-term release kinetics, confirming a synergistic mechanism combining diffusion and matrix degradation. The prepared samples were analyzed using kinetic modeling and were found to conform to the Ritger-Peppas model. This study investigates the impact of electrospun nanofiber structure and morphology on drug delivery, providing significant theoretical and practical insights for the development of innovative sustained-release formulations.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"257 ","pages":"Article 115126"},"PeriodicalIF":5.6000,"publicationDate":"2025-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Colloids and Surfaces B: Biointerfaces","FirstCategoryId":"1","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0927776525006332","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOPHYSICS","Score":null,"Total":0}
引用次数: 0
Abstract
Diclofenac sodium (DS), a non-steroidal anti-inflammatory drug used for treating inflammatory pain, has a short elimination half-life, which can lead to fluctuations in blood drug concentration. Therefore, developing sustained-release formulations is necessary to meet clinical needs. Biodegradable polymers exhibit excellent sustained-release properties and good biocompatibility, making them suitable for processing into nanofiber-based drug delivery systems via electrospinning technology. Using electrospinning combined with a non-solvent-induced phase separation mechanism, porous nanofibers with different structures were successfully prepared, including non-porous uniaxial nanofibers, porous coaxial nanofibers, double-layered nanofibers with a porous mesh surface, and porous uniaxial nanofibers. The results demonstrated that drug release is influenced by fiber structure and morphology. Among these, the coaxial porous shell-core structure(NFs 2) achieved long-term release kinetics, confirming a synergistic mechanism combining diffusion and matrix degradation. The prepared samples were analyzed using kinetic modeling and were found to conform to the Ritger-Peppas model. This study investigates the impact of electrospun nanofiber structure and morphology on drug delivery, providing significant theoretical and practical insights for the development of innovative sustained-release formulations.
期刊介绍:
Colloids and Surfaces B: Biointerfaces is an international journal devoted to fundamental and applied research on colloid and interfacial phenomena in relation to systems of biological origin, having particular relevance to the medical, pharmaceutical, biotechnological, food and cosmetic fields.
Submissions that: (1) deal solely with biological phenomena and do not describe the physico-chemical or colloid-chemical background and/or mechanism of the phenomena, and (2) deal solely with colloid/interfacial phenomena and do not have appropriate biological content or relevance, are outside the scope of the journal and will not be considered for publication.
The journal publishes regular research papers, reviews, short communications and invited perspective articles, called BioInterface Perspectives. The BioInterface Perspective provide researchers the opportunity to review their own work, as well as provide insight into the work of others that inspired and influenced the author. Regular articles should have a maximum total length of 6,000 words. In addition, a (combined) maximum of 8 normal-sized figures and/or tables is allowed (so for instance 3 tables and 5 figures). For multiple-panel figures each set of two panels equates to one figure. Short communications should not exceed half of the above. It is required to give on the article cover page a short statistical summary of the article listing the total number of words and tables/figures.